Nuclear Receptor Coregulators in Hormone-Dependent Cancers

SIMPLE SUMMARY: Altered nuclear receptor signaling is well-established to contribute to a range of hormone-dependent cancers and therefore they are therapeutic targets, for example in breast and prostate cancer. However, nuclear receptor signaling in the cancer, and in response to therapeutic target...

Descripción completa

Detalles Bibliográficos
Autores principales: Jafari, Hedieh, Hussain, Shahid, Campbell, Moray J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139824/
https://www.ncbi.nlm.nih.gov/pubmed/35626007
http://dx.doi.org/10.3390/cancers14102402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139824/
https://www.ncbi.nlm.nih.gov/pubmed/35626007
http://dx.doi.org/10.3390/cancers14102402

Ejemplares similares